📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
55
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
45%
📜 Warrant Exercise
60%
• Massive warrant overhang: 67% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split
40%
• 50-day avg $1.17 approaching $1 threshold
• 12 months cash with weak price
💰 Capital Raise
15%
• Under 12 months cash (12mo)
💹 Market Data
Market Cap$71.77M
Shares Outstanding21.85M
Float11.30M
Cash$24.42M
Debt$147.58M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 12.3% shares (2025Q4 vs prior)
29 institutional holders · 5.62M shares
#1
Fidelity National Financial, Inc.
2.80M shares
#2
Cetera Investment Advisers
1.25M shares
#3
Stonebridge Wealth Management, LLC
579.1K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest240.0K
Days to Cover4.0
% of Float2.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
8-K
8K EVENT
May 04, 2026
8-K
8K EVENT
Feb 23, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for UHG
📊 UHG FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 UHG Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.